Chromosomal aberrations in human lymphocytes exposed to the anticholinesterase pesticide isofenphos with mechanisms of leukemogenesis

Leukemia Research

Volumn 28, Issue 9, 2004, Pages 947-958

  Williams, Robert D ^a   Boros, Laszlo G ^b   Kolanko, Christopher J ^c   Jackman, Shawna M ^c   Eggers, Thomas R ^d  

^a CFE Toxicology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Auto Gentox Corp   (United States)

^d 1502 Chambers Road   (United States)

Author keywords

acetylcholine; acetylcholinesterase; ACH; ACHE; acute myelogenous leukemia; agnogenic myeloid metaplasia; AML; AMM; ARA C; CHAT; choline acetyltransferase; cytosine arabinoside; HU; hydroxyurea; IFP; isofenphos; Leukemia; OPP; organophosphate pesticide

Indexed keywords

ACETYL COENZYME A; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CYTARABINE; CYTOCHROME P450; HYDROXYUREA; ISOFENPHOS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CHOLINERGIC ACTIVITY; CHROMOSOME ABERRATION; COMET ASSAY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL;

CELLS, CULTURED; CHOLINESTERASE INHIBITORS; CHROMOSOME ABERRATIONS; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INSECTICIDES; KINETICS; LEUKEMIA; LYMPHOCYTES; MALE; ORGANOTHIOPHOSPHORUS COMPOUNDS; SEX FACTORS;

EID: 3242737375     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.12.014     Document Type: Article

References (65)

1. Douer D., Fabian I., Cline M. Circulating pluripotent haemopoetic cells in patients with myeloproliferative disorders. Br. J. Haemotol. 54:1983;373-381
2. Soreq H., Lapidot-Lifson Y., Zakut H. A role for cholinesterases in tumorigenesis? Cancer Cells. 3(12):1991;511-516
3. Stieglitz R., Gibel W., Werner W., Stobbe H. Experimental study on haematotoxic and leukaemogenic effects of trichlorophone and dimethoate. Acta Haemat. 52:1974;72-76
4. Siddiqui M.K.J., Rahman M.F., Mustafa M., Rahman M.F., Bhalerao U.T. A comparative study of blood changes and brain acetylcholinesterase inhibition by monocrotophos and its analogues in rats. Ecotoxicol. Environ. Safety. 21:1991;283-289
5. Lebailly P., Vigreux C., Lechevrel C., Ledemeney D., Godard T., Sichel F., et al. DNA damage in mononuclear leukocytes of farmers measured using the alkaline comet assay: modifications of DNA damage levels after a one-day field spraying period with selected pesticides. Cancer Epidemiol. Biomarkers Prev. 7(10):1998;929-940
6. Gogineni S.K., Elizaide A., Sanchez M.A., Verma R.S. Characterization of 7q - by FISH technique of a case with acute myelogenous leukemia evolving from agnogenic myeloid metaplasia. Leuk. Res. 19(7):1995;481-483
7. Dewald G.W., Wright P.I. Chromosome abnormalities in the myeloproliferative disorders. Semin. Oncol. 22(4):1995;341-354
8. Borrego S., Antinolo G., Martin-Noya A., Parody R. Translocation (812) in a patient with agnogenic myeloid metaplasia. Cancer Genet. Cytogenet. 71(2):1993;183-184
9. Kreipe H., Jaquet K., Felgner J., Parwaresch M.R. Clonal analysis of agnogenic myeloid metaplasia. Leuk Lymphoma. 8(6):1992;459-464
10. Kreipe H., Jaquet K., Felgner J., Radzun H.J., Parwaresch M.R. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood. 78(7):1991;1814-1817
11. Emilia G., Temperani P., Ferrari S., Zucchini P., Tagliafico E., Selleri L., et al. Cytogenetic and molecular studies in primary myelofibrosis. Cancer Genet. Cytogenet. 38(1):1989;101-113
12. Demory J.L., Dupriez B., Fenaux P., Lai J.L., Beuscart R., Jouet J.P., et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 72(3):1988;855-859
13. Harold D., Peirce T., Moskvina V., Myers A., Jones S., Hollingworth P., et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum. Genet. 113(3):2003;258-267. [Epub 21 May 2003]
14. Chan R.Y., Adatia F.A., Krupa A.M., Jasmin B.J. Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273(16):1998;9727-9733
15. Riley S.P., Talbot N.J., Ahmed M.J., Jouhal K., Hendry B.M. Characterization of human erythrocyte choline transport in chronic renal failure. Nephrol. Dial. Transplant. 12(9):1997;1921-1927
16. Ogawa H., Fujii T., Watanabe Y., Kawashima K. Expression of multiple mRNA species for choline acetyltransferase in human T-lymphocytes. Life Sci. 72(18-19):2003;2127-2130
17. Fujii T., Watanabe Y., Inoue T., Kawashima K. Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochem. Res. 28(3-4):2003;423-429
18. Tayebati S.K., El-Assouad D., Ricci A., Amenta F. Immunochemical and immunocytochemical characterization of cholinergic makers in human peripheral blood lymphocytes. J. Neuroimmunol. 132(1-2):2002;147-155
19. Wessler I., Kilbinger H., Bittinger F., Unger R., Kirkpatrick C.J. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 72(18-19):2003;2055-2061
20. Krejci E., Duval N., Chatonnet A., Vincens P., Massoulie J. Cholinesterase-like domains in enzymes and structural proteins: functional and evolutionary relationships and identification of a catalytically essential aspartic acid. Proc. Natl. Acad. Sci. U.S.A. 88(15):1991;6647-6651
21. Grisaru D., Sternfeld M., Eldor A., Glick D., Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264(3):1999;672-686
22. Oben J.A., Yang S., Lin H., Ono M., Diehl A.M. Acetylcholine promotes the proliferation and collagen gene expression of myofibroblastic hepatic stellate cells. Biochem. Biophys. Res. Commun. 300(1):2003;172-177
23. Liebermann D.A., Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Blood Cells Mol. Dis. 31:2003;213-228
24. Colley A.M., Cavanaugh H.D., Drake L.A., Law M.L. Cyclic nucleotides in muscarinic regulation of DNA and RNA polymerase activity in cultured corneal epithelial cells off the rabbit. Curr. Eye Res. 4(9):1985;941-950
25. Soreq H., Patinkin D., Lev-Lehman E., Grifman M., Ginzberg D., Eckstein F., et al. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7907-7911
26. Song P., Sekhon H.S., Proskocil B., Blusztajn J.K., Mark G.P., Spindel E.R. Synthesis of acetylcholine by lung cancer. Life Sci. 72(18-19):2003;2159- 2168
27. Boros L.G., Williams R.D. Chronic isofenphos poisoning: case report of agnogenic myeloid metaplasia with a rapid progression into acute myeloid leukemia. Leuk. Res. 22:1998;849-851
28. Boros L.G., Williams R.D. Isofenphos induced metabolic changes in K-562 myeloid blast cells. Leuk. Res. 25:2001;883-890
29. Chen H.H., Sirianni S.R., Huang C.C. Sister-chromatid exchanges and cell-cycle delay in Chinese hamster V79 cells treated with 9 organophosphorus compounds (8 pesticides and 1 defoliant). Mutat. Res. 103(3-6):1982;307-313
30. Kraynov V.S., Showalter A.K., Liu J., Zhong X., Tsai M.D. DNA polymerase beta: contributions of template-positioning and dNTP triphosphate-binding residues to catalysis and fidelity. Biochemistry. 39(51):2000;16008-16015
31. m values for the metabolism of isofenphos by P-450 liver enzymes in animals and human. Toxicol. Appl. Pharmacol. 120:1993;106-113
32. Kasagami T., Miyamoto T., Yamamoto I. Activated transformations of organophosphorus insecticides in the case of non-AChE inhibitory oxons. Pest. Manag. Sci. 58(11):2002;1107-1117
33. Jackman S.M., Grant G.M., Kolanko C.J., Stenger D.A., Nath J. DNA damage assessment by comet assay of human lymphocytes exposed to jet propulsion fuels. Environ. Mol. Mutagen. 40(1):2002;18-23
34. Ellman G.I., Courtney K.D., Ancres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95
35. Kim S.J., Letterio J. Transforming growth factor-β signaling in normal and malignant hematopoiesis. Leukemia. 17(9):2003;1731-1737
36. Glass-Marmor L., Chen-Zion M., Beitner R. Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues. Gen. Pharmacol. 27(7):1996;1241-1246
37. Dieter M.P., Maronpot R.R., French J.E. Comparison of the morphology and enzyme activity of mononuclear cells from Fischer 344 rats with either spontaneous or transplanted leukemia. Cancer Res. 45(9):1985;4301-4307
38. Zhou R., Vander Heiden M.G., Rudin C.M. Genotoxic exposure is associated with alterations in glucose uptake and metabolism. Cancer Res. 62(12):2002;3515-3520
39. Inestrosa N.C., Matthew W.D., Reiness C.G., Hall Z.W., Reichardt L.F. Atypical distribution of asymmetric acetylcholinesterase in mutant PC12 pheochromocytoma cells lacking a cell surface heparan sulfate proteoglycan. J. Neurochem. 45(1):1985;86-94
40. Wessler I.K., Kirkpatrick C.J. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol. Ther. 14(6):2001;423-434
41. Chronic Toxicity Study on Rats. Bayer AG Institute Fur Toxikologic. Report No. 37381, April 1972.
42. Lorand ICH, Souza, CA, Costa FF. Haematological toxicity associated with agricultural chemicals in Brazil, The Lancet 1984:404.
43. Reves, JD, Driggers, DA, Kiley, VA. Household Insecticide Associated Aplastic Anemia and Acute Leukemia in Children, The Lancet. 1981:300-1.
44. Maxwell D.M., Brecht K.M. Quantitative structure-activity analysis of acetylcholinesterase inhibition by oxono and thiono analogues of organophosphorus compounds. Chem. Res. Toxicol. 5(1):1992;66-71
45. Barr R.D., Koekebakker M. Acetylcholinesterase in the human erythron. III. Regulation of differentiation. Am. J. Hematol. 34(4):1990;259-261
46. Gallicchio V.S., Casale G.P., Watts T. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates. Exp. Hematol. 15(11):1987;10999-11102
47. Gallicchio V.S., Chen M.G., Gamba-Vitalo C., Watts T.D. The influence of choline chloride on murine hematopoiesis in vivo and in vitro. Int. J. Cell Cloning. 1(6):1983;451-463
48. Mantel C., Luo Z., Hendrie P., Broxmeyer H.E. Steel factor and granulocyte-macrophage colony stimulating factor act together to enhance choline-lipid turnover during synergistically stimulated proliferation of the human factor dependent cell line, M07E. Biochem. Biophys. Res. Commun. 197(2):1993;978-984
49. Carre V., Jayat C., Granet R., Krausz P., Guilloton M. Chronology of the apoptotic events induced in the K562 cell line by photodynamic treatment with hematoporphyrin and monoglucosylporphyrin. Photochem. Photobiol. 69(1):1999;55-60
50. Jedlickova K., Stockton D.W., Prchal J.T. Possible primary familial and congenital polycythemia locus at 7q22.1-7q22.2. Blood Cells Mol. Dis. 31(3):2003;327-331
51. Yamamoto M., Koshimura K., Kawaguchi M., Sohmiya M., Murakami Y., Kato Y. Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice. Neurosci. Lett. 292(2):2000;131-133
52. Levitt D.G. General continuum theory for multiion channel. II. Application to acetylcholine channel. Biophys. J. 59(2):1991;278-288
53. Li J.L., Zhu J.H., Jing Z.Z., Chen Z.C., Xiao Z.Q. [G-protein-coupled muscarinic acetylcholine receptor activation up-regulates Bcl-2 and phospho-bad via Ras-ERK-1/2 signaling pathway]. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 35(1):2003;41-48
54. Ellison V., Stillman B. Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5′ recessed DNA. PLoS Biol. 1(2):2003;E33
55. 2+ oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human T- and B-cell lines. Naunyn. Schmiedebergs Arch. Pharmacol. 362(1):2000;14-21
56. Okada S., Fukuda T., Inada K., Tokuhisa T. Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells. Blood. 93(3):1999;816-825
57. Bausero P., Schmitt M., Toussaint J.L., Simoni P., Geoffroy V., Queuche D., et al. Identification and analysis of the human choline acetyltransferase gene promoter. NeuroReport. 4(3):1993;287-290
58. Burdon D., Patel R., Challiss R.A., Blank J.L. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. Biochem. J. 367(Pt 2):2002;549-559
59. Tomizawa M., Casida J.E. Desnitro-imidacloprid activates the extracellular signal-regulated kinase cascade via the nicotinic receptor and intracellular calcium mobilization in N1E-115 cells. Toxicol. Appl. Pharmacol. 184(3):2002;180-186
60. Overstreet D.H., Djuric V. A genetic rat model of cholinergic hypersensitivity: implications for chemical intolerance, chronic fatigue, and asthma. Ann. N.Y. Acad. Sci. 933:2001;92-102
61. Yang D., Lu X., Zhang W., He F. Effect of dimethoate on the function and expression of nicotinic acetylcholine receptor in primary skeletal muscle cell culture. In Vitro Mol. Toxicol. 14(3):2001;241-245
62. Liebermann D.A., Hoffman B. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells. 12(4):1994;352-369
63. Hu X.T., Xu Y.H., Zhou Y.J. The effect of carbamylcholine on CFU-s differentiation. Int. J. Cell Cloning. 8(5):1990;377-384
64. Chatelain C., Hamood M., De Bast M., Symann M. Cholinergic enhancement of megakaryocytopoiesis and granulocytopoiesis in culture: mediation via T-lymphocytes. Exp. Hematol. 17(11):1989;1067-1071
65. Fairbairn L.J., Cowling G.J., Reipert B.M., Dexter T.M. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 74(5):1993;823-832